本页面由Tiger Trade Technology Pte. Ltd.提供服务

Castle Biosciences, Inc.

29.57
-2.3100-7.25%
盘后30.100.5300+1.79%18:09 EST
成交量:92.70万
成交额:2,732.70万
市值:8.63亿
市盈率:-68.11
高:30.50
开:29.87
低:27.22
收:31.88
52周最高:44.28
52周最低:14.59
股本:2,918.87万
流通股本:2,672.49万
量比:1.71
换手率:3.47%
股息:- -
股息率:- -
每股收益(TTM):-0.4342
每股收益(LYR):0.6200
净资产收益率:-2.69%
总资产收益率:-1.72%
市净率:1.85
市盈率(LYR):47.69

数据加载中...

2026/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/01/13

重要事件披露

Form 8-K - Current report
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/04

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/03

重要事件披露

Form 8-K - Current report
2025/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities